事前指示書 (AD) の世界市場 (～2028年)：コンポーネント (ソフトウェア・サービス)・人口構成 (高齢者層・中年層・若年層)・エンドユーザー (B2B (医療提供者・保険者)・B2C)・地域別

事前指示書 (AD) の市場規模は、2023年の1,229億米ドルから、予測期間中は18.8%のCAGRで推移し、2028年には2,911億米ドルの規模に成長すると予測されています。

ADへの投資の増加や患者のケアと自主性を強化するための政府のイニシアティブや法規制が予測期間中の市場に有利な機会を提供する見通しです。

コンポーネント別で見ると、サービスの部門が2022年のに大きなシェアを示しています。事前医療計画の重要性に対する認識が高まり、医療政策と法規制の面において、不要な介入や医療費を削減し、患者中心のケアを確保するという点で、ADのメリットが認識されるようになっています。この認識により、医療制度においてこれらのサービスが標準的な業務に統合されるようになり、同部門の急成長を牽引しています。

また、エンドユーザー別では、医療提供者の部門が2022年にかなりのシェアを示しています。医療制度において患者中心のケアと個別化治療が優先される中、終末期患者の意向、治療オプション、医療介入に関する会話を開始する上で医療提供者は重要な役割を担っています。医療提供者の専門知識と患者との信頼関係は、事前治療計画に関するデリケートな議論を効果的に進める上で重要な位置を占めています。さらに、医療提供者が電子カルテ (EHR) やデジタルツールを導入することで、ADの文書化と普及が効率化され、患者の希望へのアクセス性と実行性が高まっています。

地域別では、アジアが予測期間中に大幅な成長率を示すと予測されています。アジア市場は、進化する社会的意識、医療へのアクセスの増加、患者の自主性に対する意識の高まりを反映した要因が重なり、予測期間中に高いCAGRで成長すると予測されています。同地域では、高齢化や慢性疾患の増加など人口動態の変化に伴い、終末期医療の重要性に対する認識が高まっています。政府や医療機関は、死や終末期医療に関する議論をめぐる文化的タブーを克服し、よりオープンな対話の促進に取り組んでいます。さらに、医療インフラの進歩や患者中心のケアイニシアチブの台頭により、ADリソースへのアクセスが容易になっています。医療上の意思決定について患者が発言権を持ちたいという願望と、医療と個人の意向を一致させる取り組みが合わさり、アジアの大幅な成長を後押ししています。

当レポートでは、世界の事前指示書 (AD) の市場を調査し、市場概要、市場影響因子および市場機会の分析、技術の動向、ケーススタディ、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

• 市場力学
  • 促進要因
  • 機会
  • 課題
• 産業動向
  • ACPのデジタルトランスフォーメーション
  • データ主導型の洞察：ACPの変革
  • ACPにおける患者の関与と個別化ケアの強化
• 技術分析
• ポーターのファイブフォース分析
• 規制状況
• バリューチェーン分析
• エコシステム/市場マップ
• 特許分析
• 隣接市場分析
• ケーススタディ分析
• 主要なステークホルダーと購入基準
• 主な会議とイベント
• 購入者に影響を与える動向/ディスラプション

第6章 事前指示書 (AD) 市場：コンポーネント別

• ソフトウェア
• サービス

第7章 事前指示書 (AD) 市場：人口構成別

• 高齢者層
• 中年層
• 若年層

第8章 事前指示書 (AD) 市場：エンドユーザー別

• B2B
• B2C

第9章 事前指示書 (AD) 市場：地域別

• 北米
• 欧州
• アジア太平洋
• その他の地域

第10章 競合情勢

• 主要企業の戦略/有力企業
• 市場ランキング分析
• 企業評価マトリックス
• 競合ベンチマーキング
• 主要企業の分析
• 競合シナリオと動向

第11章 企業プロファイル

• 主要企業
  • ADVAULT, INC.
  • VYNCACARE
  • WISERCARE, INC.
  • IRIS
  • KODA HEALTH
  • THOROUGHCARE, INC.
  • VITAL DECISIONS LLC
  • AFFIRM HEALTH, INC.
  • MIDEO
  • NEW CENTURY HEALTH
  • THANACARE
  • HONOR MY DECISIONS LLC
• NPO
  • SHARP HEALTHCARE
  • ACP DECISIONS
  • BRONSON HEALTHCARE
  • ISLAND HEALTH
  • MUNSON HEALTHCARE

第12章 付録

The advance directives market is projected to reach USD 291.1 billion by 2028 from USD 122.9 billion in 2023, at a CAGR of 18.8% during the forecast period. The rising inestments in advance directives and government initiatives and regulations to enhance patient care and autonomy will provide lucrative opportunities to the market during the forecast period.

"Advance directives services segment accounted for a substantial share of the advance directives market, by component in 2022."

In 2022, the advance directives services segment accounted for a substantial share of the advance directives market. Rising awareness of the importance of proactive healthcare planning, healthcare policies and regulations are increasingly recognizing the benefits of advance directives in terms of reducing unwanted interventions, healthcare costs, and ensuring patient-centered care. This recognition has led healthcare systems to integrate these services into their standard practices, driving the segment's rapid growth.

"Healthcare Providers segment accounted for a considerable share in the advance directives market, by end user in 2022"

In 2022, the healthcare providers segment accounted for a significant share of the advance directives market. As healthcare systems prioritize patient-centered care and personalized treatment, providers play a key role in initiating conversations about end-of-life preferences, treatment options, and medical interventions. Their expertise and trusted relationships with patients position them to effectively navigate sensitive discussions surrounding advance care planning. Moreover, healthcare providers' adoption of electronic health records (EHRs) and digital tools has streamlined the documentation and dissemination of AD documents, enhancing the accessibility and implementation of patient wishes. As a result, the healthcare providers segment stands as a prominent driver of growth within the advance directives market.

"Asia to witness the substantial growth rate during the forecast period."

The Asian market is projected to grow at the high CAGR during the forecast period due to a confluence of factors that reflect evolving societal attitudes, increased healthcare access, and a growing awareness of patient autonomy. As the region undergoes demographic shifts, including an aging population and an increase in chronic diseases, there is a heightened recognition of the importance of end-of-life planning. Governments and healthcare organizations are working to overcome cultural taboos surrounding discussions of death and end-of-life care, fostering a more open dialogue. Additionally, advancements in healthcare infrastructure and a rise in patient-centered care initiatives are facilitating greater access to AD resources. The desire for patients to have a say in their medical decisions, coupled with efforts to align medical care with individual preferences, is propelling the substantial growth of AD in Asia's forecasted years.

The break-down of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Advance directives Solutions Market

The key players operating in the advance directives market include ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US).

Research Coverage:

The report analyzes the Advance directives Market and aims to estimate the market size and future growth potential of various market segments, based on components, demographics , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (increasing Investments in advance directives in developed as well as emerging technology adoption, rising demand for personalized care, increasing funding and investments in advance care planning, restraints (lack of awareness and education, communication barrier, opportunities (technological advancement and digital solutions, policy support and legislative framework), and challenges (fragmented healthcare system and lack of indiciplinary collaboration and commiunication) influencing the growth of the advance directives market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the advance directives market.
• Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the advance directives market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the advance directives market like ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US) etc.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH METHODOLOGY STEPS
  • 2.2.1 SECONDARY DATA
    • 2.2.1.1 SECONDARY SOURCES
  • 2.2.2 PRIMARY DATA
    • 2.2.2.1 PRIMARY SOURCES
    • 2.2.2.2 KEY INSIGHTS FROM PRIMARY SOURCES
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 ASSUMPTIONS FOR THE STUDY
• 2.6 LIMITATIONS
• 2.7 RISK ASSESSMENT
• 2.8 RECESSION IMPACT ON THE ADVANCE DIRECTIVESMARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • DRIVERS
  • RESTRAINTS
  • OPPORTUNITIES
  • CHALLENGES

6 INDUSTRY INSIGHTS

• 6.1 INTRODUCTION
• 6.2 INDUSTRY TRENDS
• 6.3 TECHNOLOGY ANALYSIS
• 6.4 PORTERS FIVE FORCES ANALYSIS
• 6.5 REGULATORY ANALYSIS
  • NORTH AMERICA
  • EUROPE
  • ASIA PACIFIC
• 6.6 VALUE CHAIN ANALYSIS
• 6.7 ECOSYSTEM ANALYSIS
• 6.8 PRICING ANALYSIS
• 6.9 PATENT ANALYSIS
• 6.10 ADJACENT MARKET ANALYSIS
• 6.11 CASE STUDY ANALYSIS
• 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
• 6.13 KEY CONFERENCES AND EVENTS, 2023–2024
• 6.14 TRENDS/DISRUPTIONS IMPACTING BUYERS

7 ADVANCE DIRECTIVES MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 SOFTWARE
• 7.3SERVICES

8 ADVANCE DIRECTIVES MARKET, BY DEMOGRAPHICS/AGE

• 8.1 INTRODUCTION
• 8.2 ELDERLY POPULATION (65 YEARS AND ABOVE)
• 8.3 MIDDLE-AGED ADULTS (40-64 YEARS)
• 8.4 YOUNG ADULTS (18-39 YEARS)

9 ADVANCE DIRECTIVES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 B2B CONSUMER
  • HEALTHCARE PROVIDERS
  • PAYERS
• 9.3 B2C CONSUMERS
• 9.4 OTHER END USERS

10 ADVANCE DIRECTIVES MARKET, BY REGION

• INTRODUCTION
• NORTH AMERICA
  • US
  • CANADA
• EUROPE
  • GERMANY
  • UK
  • REST OF EUROPE
• ASIA PACIFIC
  • CHINA
  • JAPAN
  • REST OF ASIA PACIFIC
• REST OF THE WORLD

11 COMPETITIVE LANDSCAPES

• OVERVIEW
• STRATEGIES ADOPTED BY KEY PLAYERS
• MARKET RANKING/SHARE ANALYSIS
• COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
• COMPANY FOOTPRINT OF PLAYERS IN ADVANCE DIRECTIVES MARKET
• COMPETITIVE SCENARIO

12 COMPANY PROFILES

• COMPANY PROFILES
  • ADVAULT, INC.
  • VYNCA INC.
  • WISERCARE
  • SHARP HEALTHCARE
  • ACP DECISION (A DBA OF NOUS FOUNDATION, INC.)
  • IRIS (ALEDADE)
  • BRONSON HEALTHCARE
  • KODA HEALTH
  • THOROUGHCARE-
  • VITAL DECISIONS LLC
  • AFFIRM HEALTH
  • MIDEO
  • NEW CENTURY HEALTH
  • VITAS HEALTHCARE
  • THANACARE
  • ISLAND HEALTH
  • HONOR MY DECISIONS

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
• 13.3 AVAILABLE CUSTOMIZATIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS